ARCHIVES

NIH Orders Duke Medical Center To Stop Enrollment In Human Research Studies

This article is from The Cancer Letter archive.

Vol. 25 No. 19 | May 14, 1999

Download PDF Visit The Full Archive

Related Articles

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

Moffitt Ends Pilot Study Based On Duke Test, Says Action Unrelated

October 23, 2009

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990